These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28105555)

  • 1. Malaria and Economic Evaluation Methods: Challenges and Opportunities.
    Drake TL; Lubell Y
    Appl Health Econ Health Policy; 2017 Jun; 15(3):291-297. PubMed ID: 28105555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy.
    Drake TL; Lubell Y; Kyaw SS; Devine A; Kyaw MP; Day NPJ; Smithuis FM; White LJ
    Appl Health Econ Health Policy; 2017 Jun; 15(3):299-306. PubMed ID: 28185133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic case for combating malaria.
    Purdy M; Robinson M; Wei K; Rublin D
    Am J Trop Med Hyg; 2013 Nov; 89(5):819-823. PubMed ID: 24197172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costing malaria interventions from pilots to elimination programmes.
    Galactionova K; Velarde M; Silumbe K; Miller J; McDonnell A; Aguas R; Smith TA; Penny MA
    Malar J; 2020 Sep; 19(1):332. PubMed ID: 32928227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalised cost-effectiveness analysis: an aid to decision making in health.
    Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
    Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-year optimization of malaria intervention: a mathematical model.
    Dudley HJ; Goenka A; Orellana CJ; Martonosi SE
    Malar J; 2016 Mar; 15():133. PubMed ID: 26931111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake.
    Merlo G; Page K; Ratcliffe J; Halton K; Graves N
    Appl Health Econ Health Policy; 2015 Jun; 13(3):303-9. PubMed ID: 25288052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Investment Case for Malaria Elimination in Thailand: A Cost-Benefit Analysis.
    Sudathip P; Kongkasuriyachai D; Stelmach R; Bisanzio D; Sine J; Sawang S; Kitchakarn S; Sintasath D; Reithinger R
    Am J Trop Med Hyg; 2019 Jun; 100(6):1445-1453. PubMed ID: 30994098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical review of health-related economic evaluations in Australia: implications for health policy.
    Salkeld G; Davey P; Arnolda G
    Health Policy; 1995 Feb; 31(2):111-25. PubMed ID: 10141252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the economic benefits of vaccines based on the health investment life course framework: a review of a broader approach to evaluate malaria vaccination.
    Constenla D
    Vaccine; 2015 Mar; 33(13):1527-40. PubMed ID: 25701316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis: from science to application.
    Berger ML; Teutsch S
    Med Care; 2005 Jul; 43(7 Suppl):49-53. PubMed ID: 16056009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations.
    Turner HC; Archer RA; Downey LE; Isaranuwatchai W; Chalkidou K; Jit M; Teerawattananon Y
    Front Public Health; 2021; 9():722927. PubMed ID: 34513790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economics of malaria control and elimination: a systematic review.
    Shretta R; Avanceña AL; Hatefi A
    Malar J; 2016 Dec; 15(1):593. PubMed ID: 27955665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Four Parenting Programs and Bibliotherapy for Parents of Children with Conduct Problems.
    Sampaio F; Enebrink P; Mihalopoulos C; Feldman I
    J Ment Health Policy Econ; 2016 Dec; 19(4):201-212. PubMed ID: 27991419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping Malaria Risk in Low Transmission Settings: Challenges and Opportunities.
    Sturrock HJW; Bennett AF; Midekisa A; Gosling RD; Gething PW; Greenhouse B
    Trends Parasitol; 2016 Aug; 32(8):635-645. PubMed ID: 27238200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. malERA: An updated research agenda for health systems and policy research in malaria elimination and eradication.
    malERA Refresh Consultative Panel on Health Systems and Policy Research
    PLoS Med; 2017 Nov; 14(11):e1002454. PubMed ID: 29190289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On time horizons in health economic evaluations.
    Haacker M; Hallett TB; Atun R
    Health Policy Plan; 2020 Nov; 35(9):1237-1243. PubMed ID: 33450767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand.
    Teerawattananon Y; Russell S
    BMC Health Serv Res; 2008 Sep; 8():197. PubMed ID: 18817579
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.